Diminution of Circulating CD4+CD25high T Cells in Na⟨ve Crohn's Disease

被引:19
作者
Chamouard, Patrick [1 ]
Monneaux, Fanny [2 ]
Richert, Zoe [1 ,2 ]
Voegeli, Anne-Claire [3 ]
Lavaux, Thomas [3 ]
Gaub, Marie Pierre [3 ]
Baumann, Rene [1 ]
Oudet, Pierre [3 ]
Muller, Sylviane [2 ]
机构
[1] Hop Hautepierre, Serv Hepatogastroenterol & Assistance Nutr, F-67098 Strasbourg, France
[2] CNRS, Inst Biol Mol & Cellulaire, UPR9021, F-67000 Strasbourg, France
[3] Hop Hautepierre, Lab Biochim & Biol Mol, F-67098 Strasbourg, France
关键词
Inflammatory bowel disease; Crohn's disease; CD4(+)CD25(high) T cells; CARD15/NOD2; gene; RHEUMATOID-ARTHRITIS; TGF-BETA; COLITIS; MICE; POPULATION; GENE; VIVO; CURE;
D O I
10.1007/s10620-008-0590-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease is considered to be caused either by an excess of T-cell effector functions and/or by a defective regulatory T-cell compartment. The aim of this study was to assess in Crohn's disease the frequency of circulating CD4(+)CD25(high) T cells that possess regulatory T-cell functions and CD4(+)CD25(low) T cells that contain activated T cells. Flow cytometry of peripheral blood was used to assess CD4(+)CD25(high) and CD4(+)CD25(low) T-cell frequencies in a cohort of 66 patients with Crohn's disease in comparison to 19 patients with ulcerative colitis and 31 healthy individuals enrolled as controls. The CD4(+)CD25(high) T-cell frequency was significantly lowered in na < ve Crohn's disease (P = 0.013) and in ulcerative colitis (P = 0.001). CD4(+)CD25(low) T-cell frequency was increased in Crohn's disease (P = 0.0001) and in ulcerative colitis (P = 0.0002). Both CD4(+)CD25(high) and CD4(+)CD25(low) T-cell frequencies are altered in na < ve Crohn's disease resulting in an imbalance between both populations and a relative contraction of the CD4(+)CD25(high) T-cell population.
引用
收藏
页码:2084 / 2093
页数:10
相关论文
共 34 条
[1]   Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[2]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[3]   Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis [J].
Cao, D ;
Malmström, V ;
Baecher-Allan, C ;
Hafler, D ;
Klareskog, L ;
Trollmo, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) :215-223
[4]   Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE [J].
Chen, Xin ;
Oppenheim, Joost J. ;
Winkler-Pickett, Robin T. ;
Ortaldo, John R. ;
Howard, O. M. Zack .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (08) :2139-2149
[5]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[6]   Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy [J].
Ehrenstein, MR ;
Evans, JG ;
Singh, A ;
Moore, S ;
Warnes, G ;
Isenberg, DA ;
Mauri, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :277-285
[7]   Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: Regulation at the interface between regulatory T cells and immune effector cells [J].
Esparza, EM ;
Arch, RH .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :1448-1465
[8]   Natalizumab for active Crohn's disease. [J].
Ghosh, S ;
Goldin, E ;
Gordon, FH ;
Malchow, HA ;
Rask-Madsen, J ;
Rutgeerts, P ;
Vyhnalek, P ;
Zádorová, Z ;
Palmer, T ;
Donoghue, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :24-32
[9]   Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease [J].
Gorelik, L ;
Flavell, RA .
IMMUNITY, 2000, 12 (02) :171-181
[10]   Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls [J].
Hart, AL ;
Kamm, MA ;
Knight, SC ;
Stagg, AJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (01) :137-145